STOCKSERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NECUpdated 2026-08-23
Here’s whether HCA Healthcare, Inc. (HCA) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Caution.
🟡
Caution
Positives: above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.10% over 10 days); 3-month momentum positive (+8.9%). Concerns: trading below the 200-day MA (long-term downtrend); declining volume on rally — weak conviction (0.78x 30d avg). Currently 22.9% off its 52-week high. Score: +0/7.
HCA is trading below its 200-day MA ($454.72) — a key warning sign the longer-term trend is under pressure. An RSI of 65.7 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +6.2% compares to +20.5% for SPY (trailed the market by 14.3%). The current 22.9% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 1 year ago→ $10,617 today
vs. S&P 500 (SPY) — same period trailed market by 14.3%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✗Above 200-day MA ($454.72)
✓Above 50-day MA ($396.64)
✓RSI(14) neutral zone (30–70) — currently 65.7
✓Positive return (+6.2%)
!Within 10% of period high (−22.9%)
Period Range $429.19
$353.99$556.52
RSI (14) 65.7
0 · OversoldOverbought · 100
Key Metrics
Price$429.19
Period Return+6.2%
Period High$556.52
Period Low$353.99
Drawdown−22.9%
MA-50$396.64
MA-200$454.72
RSI (14)65.7
Avg Volume (30d)1.6M
vs. SPYtrailed by 14.3%
Return Rank#510 of 999
Trend Signals
Price is below the 200-day moving average ($454.72)
Price is above the 50-day moving average ($396.64)